Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
November 10, 2017 Off

Sanofi develops Principa’s drug for multiple sclerosis

By Dino Mustafić

Sanofi will develop Principia Biopharma`s experimental oral treatment that could tackle multiple sclerosis (MS) and, maybe other central nervous system…

BN kicks off phase 2 study of RS virus vaccine, plans on human study next year
November 9, 2017 Off

BN kicks off phase 2 study of RS virus vaccine, plans on human study next year

By Dino Mustafić

Bavarian Nordic has started the Phase 2 extension study of MVA-BN RSV, a universal vaccine candidate designed to elicit a broad…

Positive results from Novartis’s third phase testing of Kisqali in breast cancer
November 8, 2017 Off

Positive results from Novartis’s third phase testing of Kisqali in breast cancer

By Dino Mustafić

Novartis on Wednesday announced positive topline results from the global MONALEESA-7 trial, the second Phase III trial of Kisqali in…

Diplomat to acquire Pharmaceutical Technologies
November 7, 2017 Off

Diplomat to acquire Pharmaceutical Technologies

By Dino Mustafić

Diplomat Pharmacy, has entered into a definitive agreement to acquire Pharmaceutical Technologies, doing business as National Pharmaceutical Services. The transaction…

Novartis submits MAA to EMA for CTL019 for 2 indications. Also says Cosetnyx performs well for ankylosing spondylitis patients
November 6, 2017 Off

Novartis submits MAA to EMA for CTL019 for 2 indications. Also says Cosetnyx performs well for ankylosing spondylitis patients

By Dino Mustafić

Novartis on Monday said that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for…

TiGenix converts €7M
November 6, 2017 Off

TiGenix converts €7M

By Dino Mustafić

TiGenix NV has converted €7 million of its senior unsecured convertible bonds due 2018. The company said that, through this…

Novartis, Amgen, Banner Alzheimer’s to see if investigational drug can prevent Alzheimer’s symptoms
November 3, 2017 Off

Novartis, Amgen, Banner Alzheimer’s to see if investigational drug can prevent Alzheimer’s symptoms

By Dino Mustafić

Novartis, Amgen and the Banner Alzheimer’s Institute (BAI) on Thursday revealed expanding collaboration to initiate a new trial on the…

Boehringer Ingelheim, Dicerna tema up to make treatments for chronic liver diseases
November 2, 2017 Off

Boehringer Ingelheim, Dicerna tema up to make treatments for chronic liver diseases

By Dino Mustafić

Boehringer Ingelheim and Dicerna Pharmaceuticals have announced a research collaboration and license agreement to discover and develop novel GalXC RNAi…

GSK’s investigational BCMA antibody-drug gets FDA breakthrough therapy designation
November 2, 2017 Off

GSK’s investigational BCMA antibody-drug gets FDA breakthrough therapy designation

By Dino Mustafić

GlaxoSmithKline said on Thursday that its investigational BCMA antibody-drug has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration…

Sanofi Q3 sales up, business net income $2,141
November 2, 2017 Off

Sanofi Q3 sales up, business net income $2,141

By Dino Mustafić

Sanofi’s Q3 2017 sales performance were supported by Sanofi Genzyme, Sanofi Pasteur and Emerging Markets, and it saw net sales…

Posts pagination

Previous 1 … 3,426 3,427 3,428 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine